Drug Type Small molecule drug |
Synonyms Compounds 14a-2(Liaocheng University) |
Target |
Action inhibitors |
Mechanism CYP51 family inhibitors(Cytochrome P450 family 51 inhibitors), PDL1 inhibitors(Programmed death-ligand 1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Molecular FormulaC27H28N4O3 |
InChIKeyHCSILABHNVKAFW-AREMUKBSSA-N |
CAS Registry3032391-33-3 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Infectious Diseases | Discovery | China | 26 Oct 2023 |





